Angiotech to buy AMI

Canada's Angiotech Pharmaceuticals said it will pay $758 million in cash for privately held American Medical Instruments holdings, a maker of custom needles. In the medical device world, Angiotech is perhaps best known for its collaboration with Boston Scientific on the successful Taxus stent. Angiotech plans to use the acquisition to expand into markets for specialized products for general, plastic and ophthalmic surgery as well as the vascular surgery market.

- see this article from the New York Times

Post a comment